...
首页> 外文期刊>Journal of thrombosis and thrombolysis >Intravenous thrombolysis in acute ischemic stroke due to intracranial artery dissection: a single-center case series and a review of literature
【24h】

Intravenous thrombolysis in acute ischemic stroke due to intracranial artery dissection: a single-center case series and a review of literature

机译:由于颅内动脉解剖引起的急性缺血性脑卒中静脉溶栓:单中心案例系列及文学综述

获取原文
获取原文并翻译 | 示例

摘要

Efficacy and safety of intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) due to intracranial artery dissection (IAD) are currently not established. We aimed to present a single-center experience on IAD-related AIS treated by IVT. We selected all consecutive patients with IAD-related AIS treated by IVT from a prospectively constructed single-center acute stroke registry from 2003 to 2017. We reviewed demographical, clinical and neuroimaging data and recorded hemorrhagic complications, mortality within 7 days and modified Rankin Scale at 3-months. Out of 181 AISs related to cervicocephalic dissections, 10 (5.5%) were due to IAD and five of these patients received IVT. Among these five patients, median age was 62 years; hypertension and dyslipidemia were the most frequent vascular risk factors. IAD locations were distal internal carotid artery, middle cerebral artery (M1), anterior cerebral artery (A2), and, in two cases, the basilar artery. All anterior circulation IADs were occlusive or subocclusive, while the two basilar artery IADs caused arterial stenosis. After IVT, there were no subarachnoid or symptomatic intracranial hemorrhages. One patient had an asymptomatic hemorrhagic infarct type 1. Two patients died within 7 days from ischemic mass effect. The other three patients had favorable clinical outcomes at 3-months. In this small single-center case series of IAD-related AIS, thrombolysis seemed relatively safe. However, IVT efficacy and the likelihood of arterial recanalization are still uncertain in this context. Further studies are needed to assess the safety and efficacy of IVT in these patients.
机译:目前未经颅内动脉解剖(IAD)静脉溶栓(IVT)静脉溶栓(IVT)的疗效和安全性。我们的目标是在IVT治疗的IAD相关AIS上提供单一中心经验。我们选择了IVT与IVT治疗的所有连续IAD相关AIS患者从2003年到2017年从一个前瞻性地建造的单中心急性中风登记处进行。我们在7天内审查了人口统计,临床和神经影像数据,记录了出血并发症,并在7天内进行了死亡率,并修改了Rankin规模3个月。在181人中有关患有宫颈蛋白疏散疫苗,10(5.5%)归因于IAD和其中5名患者接受IVT。在这五名患者中,中位年龄为62岁;高血压和血脂血症是最常见的血管危险因素。 IAD位置是远端内部颈动脉,中脑动脉(M1),前脑动脉(A2),两种情况下,基底动脉。所有前循环IAD都闭塞或潜伏,而两个基底动脉IAD导致动脉狭窄。 IVT后,没有蛛网膜下腔或症状颅内出血。一名患者有无症状的出血性梗死型1.两名患者在7天内从缺血性质量效应中死亡。另外三名患者在3个月内享有有利的临床结果。在这种小型单中心案例系列IAD相关的AIS中,溶栓似乎相对安全。然而,在这种情况下,IVT效力和动脉次重量的可能性仍然不确定。需要进一步的研究来评估IVT在这些患者中的安全性和功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号